PGFC
AMRX icon

Peapack-Gladstone Financial Corp’s Amneal Pharmaceuticals AMRX Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Hold
14,164
– – ﹤0.01% 627
2026
Q1 		$176K Hold
14,164
– – ﹤0.01% 639
2025
Q4 		$178K Hold
14,164
– – ﹤0.01% 638
2025
Q3 		$142K Sell
14,164
-3,846
-21% -$34.5K ﹤0.01% 664
2025
Q2 		$146K Hold
18,010
– – ﹤0.01% 654
2025
Q1 		$151K Sell
18,010
-2,862
-14% -$23.9K ﹤0.01% 653
2024
Q4 		$166K Sell
20,872
-950
-4% -$7.97K ﹤0.01% 660
2024
Q3 		$182K Sell
21,822
-900
-4% -$7.04K ﹤0.01% 664
2024
Q2 		$144K Hold
22,722
– – ﹤0.01% 657
2024
Q1 		$137K Hold
22,722
– – ﹤0.01% 669
2023
Q4 		$138K Sell
22,722
-167
-0.7% -$744 ﹤0.01% 670
2023
Q3 		$97K Hold
22,889
– – ﹤0.01% 670
2023
Q2 		$71K Hold
22,889
– – ﹤0.01% 690
2023
Q1 		$32K Hold
22,889
– – ﹤0.01% 696
2022
Q4 		$46K Sell
22,889
-300
-1% -$672 ﹤0.01% 667
2022
Q3 		$47K Hold
23,189
– – ﹤0.01% 670
2022
Q2 		$74K Buy
23,189
+2,862
+14% +$10.4K ﹤0.01% 630
2022
Q1 		$85K Hold
20,327
– – ﹤0.01% 675
2021
Q4 		$97K Hold
20,327
– – ﹤0.01% 660
2021
Q3 		$109K Sell
20,327
-2,500
-11% -$12.6K ﹤0.01% 651
2021
Q2 		$117K Hold
22,827
– – ﹤0.01% 614
2021
Q1 		$154K Hold
22,827
– – ﹤0.01% 572
2020
Q4 		$104K Sell
22,827
-2,175
-9% -$9.64K ﹤0.01% 419
2020
Q3 		$97K Buy
+25,002
New +$107K ﹤0.01% 366
2020
Q2 		– Sell
-25,002
Closed -$87K – 375
2020
Q1 		$87K Buy
+25,002
New +$106K ﹤0.01% 355

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Peapack-Gladstone Financial Corp's AMRX Position: Q2 2026 in Review

Peapack-Gladstone Financial Corp held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 14,164 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Peapack-Gladstone Financial Corp first reported a position in AMRX in Q1 2020 and has held it in 25 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Peapack-Gladstone Financial Corp held 14,164 shares of Amneal Pharmaceuticals worth $245K as of Q2 2026.
  • Peapack-Gladstone Financial Corp left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #627 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Amneal Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.